Your browser doesn't support javascript.
loading
Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes.
Steck, Andrea K; Liu, Xiang; Krischer, Jeffrey P; Haller, Michael J; Veijola, Riitta; Lundgren, Markus; Ahmed, Simi; Akolkar, Beena; Toppari, Jorma; Hagopian, William A; Rewers, Marian J; Elding Larsson, Helena.
Afiliação
  • Steck AK; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado.
  • Liu X; Health Informatics Institute, University of South Florida, Tampa, Florida.
  • Krischer JP; Health Informatics Institute, University of South Florida, Tampa, Florida.
  • Haller MJ; Department of Pediatrics, University of Florida, Gainesville, Florida.
  • Veijola R; Department of Pediatrics, PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Lundgren M; Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.
  • Ahmed S; Immunology of T1D, JDRF International, New York, New York.
  • Akolkar B; Division of Diabetes, Endocrinology and Metabolism, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
  • Toppari J; Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.
  • Hagopian WA; Pacific Diabetes Research Institute, Seattle, Washington.
  • Rewers MJ; Department of Pediatrics, Turku University Hospital, Turku, Finland.
  • Elding Larsson H; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado.
J Clin Endocrinol Metab ; 106(3): e1380-e1388, 2021 03 08.
Article em En | MEDLINE | ID: mdl-33035311
ABSTRACT
CONTEXT Understanding factors involved in the rate of C-peptide decline is needed to tailor therapies for type 1 diabetes (T1D).

OBJECTIVE:

Evaluate factors associated with rate of C-peptide decline after a T1D diagnosis in young children.

DESIGN:

Observational study.

SETTING:

Academic centers.

PARTICIPANTS:

A total of 57 participants from the Environmental Determinants of Diabetes in the Young (TEDDY) study who were enrolled at 3 months of age and followed until T1D, and 56 age-matched children diagnosed with T1D in the community. INTERVENTION A mixed meal tolerance test was used to measure the area under the curve (AUC) C-peptide at 1, 3, 6, 12, and 24 months postdiagnosis.

OUTCOME:

Factors associated with rate of C-peptide decline during the first 2 years postdiagnosis were evaluated using mixed effects models, adjusting for age at diagnosis and baseline C-peptide.

RESULTS:

Adjusted slopes of AUC C-peptide decline did not differ between TEDDY subjects and community controls (P = 0.21), although the former had higher C-peptide baseline levels. In univariate analyses combining both groups (n = 113), younger age, higher weight and body mass index z-scores, female sex, an increased number increased number of islet autoantibodies, and IA-2A or ZnT8A positivity at baseline were associated with a higher rate of C-peptide loss. Younger age, female sex, and higher weight z-score remained significant in multivariate analysis (all P < 0.02). At 3 months after diagnosis, higher HbA1c became an additional independent factor associated with a higher rate of C-peptide decline (P < 0.01).

CONCLUSION:

Younger age at diagnosis, female sex, higher weight z-score, and HbA1c were associated with a higher rate of C-peptide decline after T1D diagnosis in young children.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo C / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo C / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article